PERJETA (pertuzumab) is used for the treatment of patients with HER2-positive metastatic breast cancer

PERJETA is a HER2/neu receptor antagonist indicated in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

PERJETA (pertuzumab) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of PERJETA (pertuzumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ALUNBRIG (pertuzumab) tablets cost price in India.

The order for PERJETA (pertuzumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.

PERJETA® (pertuzumab) Injection, for intravenous use. Initial U.S. Approval: 2012

Generic Name: pertuzumab

PERJETA (pertuzumab) for injection

PERJETA (pertuzumab) for injection is available.

Get In Touch

PERJETA (pertuzumab) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand PERJETA (pertuzumab) on prescription and Import License in Patient's Name only.

For overseas patients, PERJETA (pertuzumab) can be made available in Send your enquiry to find PERJETA (pertuzumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for PERJETA (pertuzumab).

For PERJETA (pertuzumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Addition of Perjeta to Standard Care Improves Survival in HER2-Positive Early Breast Cancer For More Details

Treatment with anti-cancer drug T-DM1 after pertuzumab is 'good option For More Details

Channel Partner In India

NEW DELHI OFFICE

  • Address:60/4, T&T House. Yusuf Sarai, New Delhi:110016
  • Phone +91-11-26532129
  • Email: IPN, New Delhi

BANGALORE OFFICE

  • Address: #308, Raheja Chambers, 12, Museum Road, Bangalore 560 001
  • Email: IPN, Bangalore

KOLKATA OFFICE

  • Address: 1/A R.G Kar Road, Shayambazar, Kolkata 700004
  • Email: IPN, Kolkata

LUCKNOW OFFICE

  • Address: 203-A, 2nd Floor, Tower -11, Felix Square, IBB-2, Sushant Golf city, Lucknow 226030
  • Email: IPN, Lucknow